Skip to main content
Cardiolucent

Condition

Myopericarditis

Combined heart muscle and pericardial inflammation, monitored through recovery.

Myopericarditis is the overlap of two related conditions — inflammation of the heart muscle (myocarditis) and inflammation of the pericardial sac around the heart (pericarditis). It is most often viral or post-viral in origin, though similar etiologies as isolated myocarditis or pericarditis apply. Patients typically present with both pleuritic chest pain (characteristic of pericarditis) and biomarker elevation or EKG changes suggesting muscle involvement (characteristic of myocarditis). The prognosis is generally favorable, with most patients making a full recovery, but recurrence and persistent ventricular dysfunction are recognized complications. Dr. Kedan provides recovery monitoring, anti-inflammatory therapy, and guidance on safe return to exercise.

What Cardiolucent Evaluates

  • Detailed history of preceding illness, symptoms, and previous episodes
  • Echocardiography to evaluate ventricular function and pericardial effusion
  • POCUS at every visit for serial reassessment
  • EKG monitoring for evolution and rhythm disturbances
  • Biomarker trends (troponin, inflammatory markers)
  • Cardiac MRI coordination with Cedars-Sinai when needed
  • Anti-inflammatory regimen management and exercise guidance

Common Symptoms

  • Chest pain that is often sharp, pleuritic, and worse when lying flat or inhaling
  • Pain that improves with sitting forward
  • Shortness of breath or palpitations
  • Fatigue and malaise, often after a viral illness
  • Low-grade fever
  • Symptoms of acute heart failure in more severe cases

Risk Factors

  • Recent viral infection
  • Autoimmune or systemic inflammatory diseases
  • Certain medications (including some chemotherapy and immune checkpoint inhibitors)
  • Prior episode of pericarditis or myocarditis
  • Younger age, with male predominance
  • Post-cardiac surgery or post-myocardial infarction in select cases

How Cardiolucent Approaches Treatment

Treatment combines features of both conditions. NSAIDs and colchicine — the cornerstone of pericarditis therapy — are typically used unless the myocarditis component is severe. Standard heart failure medications are added if ventricular function is reduced. Exercise restriction during the acute and early recovery phase is important, with gradual return guided by serial echocardiography. Dr. Kedan monitors recovery carefully, watches for recurrence, and coordinates with rheumatology when an autoimmune contribution is suspected.

Common Questions

Frequently Asked Questions

What is myopericarditis?
Myopericarditis is concurrent inflammation of the heart muscle (myocardium) and the pericardial sac around the heart. It overlaps the clinical features of myocarditis and pericarditis.
How is it different from myocarditis or pericarditis alone?
Pure pericarditis affects only the sac around the heart and does not raise troponin. Pure myocarditis affects the muscle and may not have the pleuritic pain pattern of pericarditis. Myopericarditis has features of both — pleuritic chest pain plus evidence of muscle involvement on EKG or biomarkers.
How is it diagnosed?
Diagnosis combines history, EKG findings, biomarker elevation, and imaging. Echocardiography evaluates both ventricular function and pericardial effusion. Cardiac MRI is often very informative, showing patterns of both pericardial and myocardial inflammation.
How is it treated?
Most patients are treated with NSAIDs and colchicine, which form the cornerstone of pericarditis therapy. Colchicine in particular reduces the risk of recurrence. If significant ventricular dysfunction is present, the regimen is adjusted and heart failure medications are added.
Will my heart recover?
Most patients recover fully. A minority have persistent ventricular dysfunction, and a subset experience recurrent episodes. Long-term follow-up with serial imaging is important during the recovery phase.
Can myopericarditis come back?
Yes — recurrence is one of the recognized complications, particularly when colchicine is stopped too early. The duration of colchicine therapy after a first episode is typically several months, with longer courses for recurrent disease. Dr. Kedan tailors duration to the specific course.
Do I need to avoid exercise?
Yes, during the acute and early recovery phase. Strenuous exercise, particularly competitive athletics, should be avoided for several months, with return guided by symptoms, biomarkers, and imaging. Dr. Kedan provides individualized guidance based on the severity of muscle involvement.
Is myopericarditis caused by infections?
Most cases are viral or post-viral. Other infections, autoimmune disease, certain medications, and post-cardiac surgery or post-myocardial infarction processes can also cause it. The specific cause often remains unidentified.
What follow-up will I need?
Repeat echocardiography over the months following the acute episode, biomarker trends, and clinical assessment guide the recovery process. POCUS at office visits provides interval reassessment. Cardiac MRI may be used when more detailed assessment is helpful.
How do I schedule a consultation?
Call (310) 304-5555 or use the contact form to schedule with Dr. Kedan at the Beverly Hills office. Cardiolucent does not bill Medicare or insurance; a detailed superbill is provided for any out-of-network reimbursement.

Explore

Related Conditions

Structured follow-up after myopericarditis.

Schedule a consultation with Dr. Kedan in Beverly Hills.
Schedule an Appointment

Medical Disclaimer

The information on this site is for general educational purposes only and is not medical advice, diagnosis, or treatment. Reading this site does not create a doctor–patient relationship. Always consult a qualified healthcare professional for personal guidance. If this is an emergency, call 911. Mentions of medications, devices, or procedures are informational and not endorsements. Full medical disclaimer.

†Some listed indications involve investigational/off-label use. Learn more.